Clinical Leader Webinar
-
Scaling Pharmacovigilance: From Clinical Development to Commercialization
10/1/2026
Commercial growth brings new PV challenges. Gain practical insights on operating models, technology, governance, and leadership for long-term success.
-
The Future Of Clinical Trials: AI, Real-Time Data, And FDA Innovation
9/30/2026
How does building trial protocols into health records lets key safety and efficacy signals reach sponsors and regulators in days, cutting manual data entry and speeding decisions.
-
Speed Meets Precision: Accelerating Oncology With Smarter Data
9/28/2026
This webinar will explore how oncology sponsors are modernizing data flow, analytics, and cross-functional collaboration to support faster, more informed trial decisions without compromising quality.
- What's Actually Working In AI-Enabled Respiratory Trials 9/24/2026
-
ISPOR Top 10 HEOR Trends: What Are The Key Themes For 2026-27?
9/22/2026
Healthcare decision-making is evolving fast. Discover how AI, RWE, and changing HTA frameworks are influencing pricing, patient engagement, and market access.
-
How Some Patient Organizations Are Driving Drug Development
9/17/2026
Discover how patient-led registries are becoming a practical source of real-world evidence, drug repurposing insight, and smarter trial design.
-
The Evidence Gap In Hematology: From Trial Endpoints To Patient Outcomes
9/16/2026
Hematology trials face shrinking patient pools and fierce competition. Discover how real-world data and evidence can sharpen feasibility, site selection, and regulatory strategy.
-
A New Chapter for Orexin Therapies: What's Changing in Drug Development
9/16/2026
Join Beatrice Setnik, PhD and Denise Milova, PhD, for a conversation on orexin rescheduling and the evolving regulatory landscape.
-
The Agentic AI Use Cases Already Transforming Clinical Trials
9/8/2026
Leaders from AstraZeneca, Syneos Health, Sarah Cannon Research Institute, and Medable get candid about where agentic AI is actually earning its keep.
-
AI Reality Check In Drug Development: What's Real And What's Missing
9/1/2026
Where does AI actually add value in drug development—and where does human expertise still matter? Explore practical answers for trial teams navigating the hype.